US Patent Issued to TASRIF PHARMACEUTICAL on July 28 for "Antibodies and antigen binding fragments against CD155 methods of use thereof" (British, American Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,321, issued on July 28, was assigned to TASRIF PHARMACEUTICAL LLC (Farmingdale, N.Y.).

"Antibodies and antigen binding fragments against CD155 methods of use thereof" was invented by Aftab S. Karim (Farmington, N.Y.), Robert Holgate (Babraham, Great Britain) and Arron Hearn (Babraham, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "A humanized antibody or antigen binding fragment that binds to the poliovirus receptor (PVR) can be utilized in the preparation of antibody drug conjugates (ADCs) to target nucleic acids, peptides and proteins, drugs and radiopharmaceuticals to cancer cells. These antibodies or antigen binding fragments can a...